Veracity Capital LLC’s Regeneron Pharmaceuticals Position
Does Veracity Capital LLC own Regeneron Pharmaceuticals (REGN)? Yes — 5.6K shares worth $4M (+1.53% of its 13F portfolio) as of Q1 2026, down from 5.6K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
5.6K
% of Portfolio
+1.53%
Quarters Held
25
currently held
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 5.6K | $4M | +1.53% |
| Q4 2025 | 5.6K | $4M | +1.28% |
| Q3 2025 | 5.6K | $3M | +1.01% |
| Q2 2025 | 5.6K | $3M | +1.01% |
| Q1 2025 | 5.6K | $4M | +1.38% |
| Q4 2024 | 5.6K | $4M | +1.44% |
| Q3 2024 | 5.7K | $6M | +2.26% |
| Q2 2024 | 5.8K | $6M | +2.54% |
| Q1 2024 | 6.1K | $6M | +2.29% |
| Q4 2023 | 6.4K | $6M | +2.24% |
| Q3 2023 | 6.5K | $5M | +2.47% |
| Q2 2023 | 6.5K | $5M | +1.99% |
| Q1 2023 | 6.5K | $5M | +2.47% |
| Q4 2022 | 6.8K | $5M | +2.35% |
| Q3 2022 | 6.9K | $5M | +2.60% |
| Q2 2022 | 6.9K | $4M | +2.18% |
| Q1 2022 | 7.0K | $5M | +2.04% |
| Q4 2021 | 7.3K | $5M | +1.84% |
| Q3 2021 | 7.2K | $4M | +1.88% |
| Q2 2021 | 7.8K | $4M | +1.01% |
| Q1 2021 | 7.9K | $4M | +1.49% |
| Q4 2020 | 8.6K | $4M | +2.01% |
| Q3 2020 | 8.2K | $5M | +2.43% |
| Q2 2020 | 8.0K | $5M | +2.72% |
| Q1 2020 | 16.2K | $8M | +2.29% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Veracity Capital LLC’s full portfolio or all institutional holders of REGN.